During the past decade, Beth Israel Comprehensive Cancer Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beth Israel Comprehensive Cancer Center" #1 collaborator was "AbbVie" with 1 trials as a collaborator and "Celgene" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Beth Israel Comprehensive Cancer Center" are "Acute Myeloid Leukemia" (1 trials), "Acute Myeloid Leukemia (AML)" (1 trials), "Chronic Myelomonocytic Leukemia" (1 trials), "Multiple Myeloma" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "Beth Israel Comprehensive Cancer Center" in a lesser frequency.

Most popular intervention types in "Beth Israel Comprehensive Cancer Center" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "5-Azacytidine" (1 trials), "Dexamethasone" (1 trials), "Elotuzumab" (1 trials), "Panobinostat" (1 trials) and "Panobinostat (LBH589)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Beth Israel Comprehensive Cancer Center" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Beth Israel Comprehensive Cancer Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Beth Israel Comprehensive Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Beth Israel Comprehensive Cancer Center, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".